Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3155224 | 0.92 | ALDH1A1 (0.48) | NAAACES2EPHX1TSHRDGKA | |
| SCHEMBL1960272 | 0.91 | NAAA (0.48) | NAAACES2EPHX1TSHRLPAR3 | |
| SCHEMBL2217467 | 0.89 | NAAA (0.52) | NAAAEPHX1TSHRALDH1A1HCAR2 | |
| SCHEMBL6761300 | 0.87 | NAAA (0.55) | NAAAEPHX1TSHRDGKAALDH1A1 | |
| SCHEMBL7064624 | 0.87 | NAAA (0.55) | NAAAEPHX1TSHRDGKAALDH1A1 | |
| SCHEMBL3134246 | 0.87 | NAAA (0.55) | NAAAEPHX1TSHRDGKAALDH1A1 | |
| SCHEMBL8894962 | 0.87 | NAAA (0.45) | NAAACES2EPHX1TSHRLPAR3 | |
| SCHEMBL10476907 | 0.87 | NAAA (0.55) | NAAAEPHX1TSHRDGKAALDH1A1 | |
| SCHEMBL2940549 | 0.87 | NAAA (0.55) | NAAAEPHX1TSHRDGKAALDH1A1 | |
| SCHEMBL382595 | 0.85 | NAAA (0.48) | NAAACES2EPHX1TSHRDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2748243-B1 | BROMINATED FLAME RETARDANT, ANTIMONY OXIDE FREE POLYMER FORMULATIONS | CHEMTURA CORP (US) | 2015-11-18 | — | — | EP | disclosed |
| CN-104795595-A | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES | 2015-07-22 | — | — | CN | disclosed |
| CN-102498605-B | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES | 2015-05-20 | — | — | CN | disclosed |
| US-8889770-B2 | Brominated flame retardant, antimony oxide free polymer formulations | CHEMTURA CORPORATION (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2748243-A1 | BROMINATED FLAME RETARDANT, ANTIMONY OXIDE FREE POLYMER FORMULATIONS | Chemtura Corporation (US) | 2014-07-02 | — | — | EP | disclosed |
| WO-2014027251-A2 | AMINOPYRIDINE COMPOUNDS AND THEIR USES | MS THERAPEUTICS LIMITED (GB) | 2014-02-20 | — | — | WO | disclosed |
| US-20140024621-A1 | AMINOPYRIDINE COMPOUNDS AND THEIR USES | MS THERAPEUTICS LIMITED (GB) | 2014-01-23 | — | — | US | disclosed |
| US-20130053482-A1 | Brominated Flame Retardant, Antimony Oxide Free Polymer Formulations | CHEMTURA CORPORATION (US) | 2013-02-28 | — | — | US | disclosed |
| WO-2013028344-A1 | BROMINATED FLAME RETARDANT, ANTIMONY OXIDE FREE POLYMER FORMULATIONS | CHEMTURA CORPORATION (US) | 2013-02-28 | — | — | WO | disclosed |
| CN-102498605-A | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES | 2012-06-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024621-A1 | AMINOPYRIDINE COMPOUNDS AND THEIR USES | DNPEP, PEPD, ANPEP | NAAA 66/4885CES2 89/4885EPHX1 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.